The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ARYA SCIENCES ACQUISITN CORP CLASS A ORD SHS G31658100 2,910 300,000 SH   SOLE   300,000 0 0
CAREMAX INC *W EXP 06/08/202 14171W111 64 45,960 SH   SOLE   45,960 0 0
COMPASS THERAPEUTICS INC COM 20454B104 11,165 3,500,000 SH   SOLE   3,500,000 0 0
GLOBUS MED INC CL A 379577208 26,949 373,254 SH   SOLE   373,254 0 0
HELIX ACQUISITION CORP COM CL A G4444C102 1,484 150,000 SH   SOLE   150,000 0 0
JIYA ACQUISITION CORP COM CL A 47760M102 2,931 300,000 SH   SOLE   300,000 0 0
MEDICUS SCIENCES ACQUISITION *W EXP 02/12/202 G5960S124 24 33,331 SH   SOLE   33,331 0 0
MEDICUS SCIENCES ACQUISITION CL A SHS G5960S108 2,916 300,000 SH   SOLE   300,000 0 0
PANACEA ACQUISITION CORP II CL A SHS G6882C106 1,940 200,000 SH   SOLE   200,000 0 0
RESEARCH ALLIANCE CORP II COM CL A 760873109 2,931 300,000 SH   SOLE   300,000 0 0
SILENCE THERAPEUTICS PLC ADS 82686Q101 18,115 758,253 SH   SOLE   758,253 0 0
SURROZEN INC *W EXP 08/01/203 86889P117 1,331 1,165,832 SH   SOLE   1,165,832 0 0
SURROZEN INC COM 86889P109 22,359 3,497,500 SH   SOLE   3,497,500 0 0
TANDEM DIABETES CARE INC COM NEW 875372203 45,256 300,664 SH   SOLE   300,664 0 0
UNITED THERAPEUTICS CORP DEL COM 91307C102 12,930 59,838 SH   SOLE   59,838 0 0